{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T08:24:17Z","timestamp":1772526257727,"version":"3.50.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Adenovirus-based vectors are among the most commonly used platforms for gene delivery and gene therapy studies. One of the obstacles for potential application is dose-related toxicity. We show here that adenovirus infection and Ad-mediated gene delivery can be enhanced by inhibitors of bromodomain and extra-terminal (BET) family proteins. We showed that JQ1, but not its inactive enantiomer (\u2212)-JQ1, dose-dependently promoted Ad infection and Ad-mediated gene delivery in both epithelial and lymphocyte cells. Given orally, JQ1 also enhanced transgene expression in a murine tumor model. Inhibitors of histone deacetylases (HDACi) are among the commonly reported small molecule compounds which enhance Ad-mediated gene delivery. We found that JQ1 treatment did not cause histone acetylation nor expression of Ad attachment receptor CAR. Instead, JQ1 treatment induced an increase in BRD4 association with CDK9, a subunit of P-TEFb of transcription elongation. Concurrently, we showed that CDK9 inhibition blocked Ad infection and JQ1 enhancement on the infection. The study exemplifies the potentials of BET inhibitors like JQ1 in oncolytic virotherapy.<\/jats:p>","DOI":"10.1038\/s41598-018-28421-x","type":"journal-article","created":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T10:35:47Z","timestamp":1532601347000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Enhancement of adenovirus infection and adenoviral vector-mediated gene delivery by bromodomain inhibitor JQ1"],"prefix":"10.1038","volume":"8","author":[{"given":"Baojie","family":"Lv","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujie","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3065-1336","authenticated-orcid":false,"given":"Erguang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,1]]},"reference":[{"key":"28421_CR1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.gendis.2017.04.001","volume":"4","author":"CS Lee","year":"2017","unstructured":"Lee, C. S. et al. Adenovirus-Mediated Gene Delivery: Potential Applications for Gene and Cell-Based Therapies in the New Era of Personalized Medicine. Genes Dis 4, 43\u201363, https:\/\/doi.org\/10.1016\/j.gendis.2017.04.001 (2017).","journal-title":"Genes Dis"},{"key":"28421_CR2","doi-asserted-by":"publisher","unstructured":"Ginn, S. L., Amaya, A. K., Alexander, I. E., Edelstein, M. & Abedi, M. R. Gene therapy clinical trials worldwide to 2017: An update. J Gene Med, e3015, https:\/\/doi.org\/10.1002\/jgm.3015 (2018).","DOI":"10.1002\/jgm.3015"},{"key":"28421_CR3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1089\/hum.2017.238","volume":"29","author":"Q Lin","year":"2018","unstructured":"Lin, Q., Wang, D. G., Zhang, Z. Q. & Liu, D. P. Applications of Virus Vector-Mediated Gene Therapy in China. Hum Gene Ther 29, 98\u2013109, https:\/\/doi.org\/10.1089\/hum.2017.238 (2018).","journal-title":"Hum Gene Ther"},{"key":"28421_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2147\/OV.S63047","volume":"5","author":"K Sweeney","year":"2016","unstructured":"Sweeney, K. & Hallden, G. Oncolytic adenovirus-mediated therapy for prostate cancer. Oncolytic Virother 5, 45\u201357, https:\/\/doi.org\/10.2147\/OV.S63047 (2016).","journal-title":"Oncolytic Virother"},{"key":"28421_CR5","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nrg1066","volume":"4","author":"CE Thomas","year":"2003","unstructured":"Thomas, C. E., Ehrhardt, A. & Kay, M. A. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 4, 346\u2013358, https:\/\/doi.org\/10.1038\/nrg1066 (2003).","journal-title":"Nat Rev Genet"},{"key":"28421_CR6","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2174\/1566523213666131125095046","volume":"13","author":"WS Wold","year":"2013","unstructured":"Wold, W. S. & Toth, K. Adenovirus vectors for gene therapy, vaccination and cancer gene therapy. Curr Gene Ther 13, 421\u2013433 (2013).","journal-title":"Curr Gene Ther"},{"key":"28421_CR7","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1126\/science.275.5304.1320","volume":"275","author":"JM Bergelson","year":"1997","unstructured":"Bergelson, J. M. et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275, 1320\u20131323 (1997).","journal-title":"Science"},{"key":"28421_CR8","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1073\/pnas.94.7.3352","volume":"94","author":"RP Tomko","year":"1997","unstructured":"Tomko, R. P., Xu, R. & Philipson, L. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci USA 94, 3352\u20133356 (1997).","journal-title":"Proc Natl Acad Sci USA"},{"key":"28421_CR9","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.tim.2007.10.001","volume":"15","author":"PL Stewart","year":"2007","unstructured":"Stewart, P. L. & Nemerow, G. R. Cell integrins: commonly used receptors for diverse viral pathogens. Trends Microbiol 15, 500\u2013507, https:\/\/doi.org\/10.1016\/j.tim.2007.10.001 (2007).","journal-title":"Trends Microbiol"},{"key":"28421_CR10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/0092-8674(93)90231-E","volume":"73","author":"TJ Wickham","year":"1993","unstructured":"Wickham, T. J., Mathias, P., Cheresh, D. A. & Nemerow, G. R. Integrins \u03b1v\u03b23 and \u03b1v\u03b25 promote adenovirus internalization but not virus attachment. Cell 73, 309\u2013319 (1993).","journal-title":"Cell"},{"key":"28421_CR11","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/sj.mt.6300206","volume":"15","author":"AH Baker","year":"2007","unstructured":"Baker, A. H., McVey, J. H., Waddington, S. N., Di Paolo, N. C. & Shayakhmetov, D. M. The influence of blood on in vivo adenovirus bio-distribution and transduction. Mol Ther 15, 1410\u20131416, https:\/\/doi.org\/10.1038\/sj.mt.6300206 (2007).","journal-title":"Mol Ther"},{"key":"28421_CR12","doi-asserted-by":"publisher","first-page":"e1001142","DOI":"10.1371\/journal.ppat.1001142","volume":"6","author":"AC Bradshaw","year":"2010","unstructured":"Bradshaw, A. C. et al. Requirements for receptor engagement during infection by adenovirus complexed with blood coagulation factor X. Plos Pathog 6, e1001142, https:\/\/doi.org\/10.1371\/journal.ppat.1001142 (2010).","journal-title":"Plos Pathog"},{"key":"28421_CR13","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1517\/17425247.2014.938637","volume":"11","author":"E Lopez-Gordo","year":"2014","unstructured":"Lopez-Gordo, E., Denby, L., Nicklin, S. A. & Baker, A. H. The importance of coagulation factors binding to adenovirus: historical perspectives and implications for gene delivery. Expert Opin Drug Deliv 11, 1795\u20131813, https:\/\/doi.org\/10.1517\/17425247.2014.938637 (2014).","journal-title":"Expert Opin Drug Deliv"},{"key":"28421_CR14","doi-asserted-by":"publisher","unstructured":"Bilsland, A. E., Spiliopoulou, P. & Evans, T. R. Virotherapy: cancer gene therapy at last? F1000Res 5, https:\/\/doi.org\/10.12688\/f1000research.8211.1 (2016).","DOI":"10.12688\/f1000research.8211.1"},{"key":"28421_CR15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nature18317","volume":"535","author":"DC Avgousti","year":"2016","unstructured":"Avgousti, D. C. et al. A core viral protein binds host nucleosomes to sequester immune danger signals. Nature 535, 173\u2013177, https:\/\/doi.org\/10.1038\/nature18317 (2016).","journal-title":"Nature"},{"key":"28421_CR16","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/sj.cgt.7700939","volume":"13","author":"RL VanOosten","year":"2006","unstructured":"VanOosten, R. L., Earel, J. K. Jr. & Griffith, T. S. Enhancement of Ad5-TRAIL cytotoxicity against renal cell carcinoma with histone deacetylase inhibitors. Cancer Gene Therapy 13, 628\u2013632, https:\/\/doi.org\/10.1038\/sj.cgt.7700939 (2006).","journal-title":"Cancer Gene Therapy"},{"key":"28421_CR17","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1093\/nar\/gkq783","volume":"39","author":"T Komatsu","year":"2011","unstructured":"Komatsu, T., Haruki, H. & Nagata, K. Cellular and viral chromatin proteins are positive factors in the regulation of adenovirus gene expression. Nucleic Acids Res 39, 889\u2013901, https:\/\/doi.org\/10.1093\/nar\/gkq783 (2011).","journal-title":"Nucleic Acids Res"},{"key":"28421_CR18","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.3390\/v5061500","volume":"5","author":"CM Wong","year":"2013","unstructured":"Wong, C. M., McFall, E. R., Burns, J. K. & Parks, R. J. The role of chromatin in adenoviral vector function. Viruses 5, 1500\u20131515, https:\/\/doi.org\/10.3390\/v5061500 (2013).","journal-title":"Viruses"},{"key":"28421_CR19","doi-asserted-by":"publisher","first-page":"4868","DOI":"10.3892\/ol.2017.6069","volume":"13","author":"J Ma","year":"2017","unstructured":"Ma, J. et al. Histone deacetylase inhibitor trichostatin A enhances the antitumor effect of the oncolytic adenovirus H101 on esophageal squamous cell carcinoma in vitro and in vivo. Oncol Lett 13, 4868\u20134874, https:\/\/doi.org\/10.3892\/ol.2017.6069 (2017).","journal-title":"Oncol Lett"},{"key":"28421_CR20","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","volume":"128","author":"T Kouzarides","year":"2007","unstructured":"Kouzarides, T. Chromatin modifications and their function. Cell 128, 693\u2013705, https:\/\/doi.org\/10.1016\/j.cell.2007.02.005 (2007).","journal-title":"Cell"},{"key":"28421_CR21","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1101\/gr.132308.111","volume":"22","author":"R Ferrari","year":"2012","unstructured":"Ferrari, R. et al. Reorganization of the host epigenome by a viral oncogene. Genome Res 22, 1212\u20131221, https:\/\/doi.org\/10.1101\/gr.132308.111 (2012).","journal-title":"Genome Res"},{"key":"28421_CR22","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.chom.2014.10.004","volume":"16","author":"R Ferrari","year":"2014","unstructured":"Ferrari, R. et al. Adenovirus small E1A employs the lysine acetylases p300\/CBP and tumor suppressor Rb to repress select host genes and promote productive virus infection. Cell Host Microbe 16, 663\u2013676, https:\/\/doi.org\/10.1016\/j.chom.2014.10.004 (2014).","journal-title":"Cell Host Microbe"},{"key":"28421_CR23","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nrg2539","volume":"10","author":"R Ferrari","year":"2009","unstructured":"Ferrari, R., Berk, A. J. & Kurdistani, S. K. Viral manipulation of the host epigenome for oncogenic transformation. Nat Rev Genet 10, 290\u2013294, https:\/\/doi.org\/10.1038\/nrg2539 (2009).","journal-title":"Nat Rev Genet"},{"key":"28421_CR24","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/382319a0","volume":"382","author":"XJ Yang","year":"1996","unstructured":"Yang, X. J., Ogryzko, V. V., Nishikawa, J., Howard, B. H. & Nakatani, Y. A p300\/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382, 319\u2013324, https:\/\/doi.org\/10.1038\/382319a0 (1996).","journal-title":"Nature"},{"key":"28421_CR25","doi-asserted-by":"publisher","first-page":"8409","DOI":"10.1128\/JVI.00796-09","volume":"83","author":"PJ Ross","year":"2009","unstructured":"Ross, P. J., Kennedy, M. A. & Parks, R. J. Host cell detection of noncoding stuffer DNA contained in helper-dependent adenovirus vectors leads to epigenetic repression of transgene expression. J Virol 83, 8409\u20138417, https:\/\/doi.org\/10.1128\/JVI.00796-09 (2009).","journal-title":"J Virol"},{"key":"28421_CR26","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.yexcr.2005.10.026","volume":"312","author":"T Watanabe","year":"2006","unstructured":"Watanabe, T. et al. Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells. Experimental Cell Research 312, 256\u2013265, https:\/\/doi.org\/10.1016\/j.yexcr.2005.10.026 (2006).","journal-title":"Experimental Cell Research"},{"key":"28421_CR27","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1158\/1535-7163.MCT-06-0431","volume":"6","author":"ME Goldsmith","year":"2007","unstructured":"Goldsmith, M. E. et al. The histone deacetylase inhibitor FK228 given prior to adenovirus infection can boost infection in melanoma xenograft model systems. Molecular Cancer Therapeutics 6, 496\u2013505, https:\/\/doi.org\/10.1158\/1535-7163.MCT-06-0431 (2007).","journal-title":"Molecular Cancer Therapeutics"},{"key":"28421_CR28","doi-asserted-by":"publisher","unstructured":"Danielsson, A., Dzojic, H., Rashkova, V., Cheng, W. S. & Essand, M. The HDAC inhibitor FK228 enhances adenoviral transgene expression by a transduction-independent mechanism but does not increase adenovirus replication. Plos One 6, https:\/\/doi.org\/10.1371\/journal.pone.0014700 (2011).","DOI":"10.1371\/journal.pone.0014700"},{"key":"28421_CR29","doi-asserted-by":"publisher","unstructured":"Taniguchi, Y. The Bromodomain and Extra-Terminal Domain (BET) Family: Functional Anatomy of BET Paralogous Proteins. Int J Mol Sci 17, https:\/\/doi.org\/10.3390\/ijms17111849 (2016).","DOI":"10.3390\/ijms17111849"},{"key":"28421_CR30","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/20974","volume":"399","author":"C Dhalluin","year":"1999","unstructured":"Dhalluin, C. et al. Structure and ligand of a histone acetyltransferase bromodomain. Nature 399, 491\u2013496, https:\/\/doi.org\/10.1038\/20974 (1999).","journal-title":"Nature"},{"key":"28421_CR31","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1021\/cb500996u","volume":"10","author":"M Brand","year":"2015","unstructured":"Brand, M. et al. Small molecule inhibitors of bromodomain-acetyl-lysine interactions. ACS Chem Biol 10, 22\u201339, https:\/\/doi.org\/10.1021\/cb500996u (2015).","journal-title":"ACS Chem Biol"},{"key":"28421_CR32","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/nature09504","volume":"468","author":"P Filippakopoulos","year":"2010","unstructured":"Filippakopoulos, P. et al. Selective inhibition of BET bromodomains. Nature 468, 1067\u20131073, https:\/\/doi.org\/10.1038\/nature09504 (2010).","journal-title":"Nature"},{"key":"28421_CR33","doi-asserted-by":"publisher","first-page":"13690","DOI":"10.1073\/pnas.0705053104","volume":"104","author":"DA Bisgrove","year":"2007","unstructured":"Bisgrove, D. A., Mahmoudi, T., Henklein, P. & Verdin, E. Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription. Proc Natl Acad Sci USA 104, 13690\u201313695, https:\/\/doi.org\/10.1073\/pnas.0705053104 (2007).","journal-title":"Proc Natl Acad Sci USA"},{"key":"28421_CR34","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.1128\/JVI.03068-12","volume":"87","author":"X Wang","year":"2013","unstructured":"Wang, X., Helfer, C. M., Pancholi, N., Bradner, J. E. & You, J. Recruitment of Brd4 to the human papillomavirus type 16 DNA replication complex is essential for replication of viral DNA. J Virol 87, 3871\u20133884, https:\/\/doi.org\/10.1128\/JVI.03068-12 (2013).","journal-title":"J Virol"},{"key":"28421_CR35","doi-asserted-by":"publisher","first-page":"e1005950","DOI":"10.1371\/journal.ppat.1005950","volume":"12","author":"K Ren","year":"2016","unstructured":"Ren, K. et al. An Epigenetic Compound Library Screen Identifies BET Inhibitors That Promote HSV-1 and -2 Replication by Bridging P-TEFb to Viral Gene Promoters through BRD4. Plos Pathog 12, e1005950, https:\/\/doi.org\/10.1371\/journal.ppat.1005950 (2016).","journal-title":"Plos Pathog"},{"key":"28421_CR36","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1073\/pnas.95.5.2509","volume":"95","author":"TC He","year":"1998","unstructured":"He, T. C. et al. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 95, 2509\u20132514 (1998).","journal-title":"Proc Natl Acad Sci USA"},{"key":"28421_CR37","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/nprot.2007.135","volume":"2","author":"J Luo","year":"2007","unstructured":"Luo, J. et al. A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat Protoc 2, 1236\u20131247, https:\/\/doi.org\/10.1038\/nprot.2007.135 (2007).","journal-title":"Nat Protoc"},{"key":"28421_CR38","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/bph.12408","volume":"171","author":"TK Albert","year":"2014","unstructured":"Albert, T. K. et al. Characterization of molecular and cellular functions of the cyclin-dependent kinase CDK9 using a novel specific inhibitor. Br J Pharmacol 171, 55\u201368, https:\/\/doi.org\/10.1111\/bph.12408 (2014).","journal-title":"Br J Pharmacol"},{"key":"28421_CR39","doi-asserted-by":"publisher","first-page":"31793","DOI":"10.1074\/jbc.M102306200","volume":"276","author":"SH Chao","year":"2001","unstructured":"Chao, S. H. & Price, D. H. Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo. J Biol Chem 276, 31793\u201331799, https:\/\/doi.org\/10.1074\/jbc.M102306200 (2001).","journal-title":"J Biol Chem"},{"key":"28421_CR40","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65, 55\u201363 (1983).","journal-title":"J Immunol Methods"},{"key":"28421_CR41","first-page":"5447","volume":"48","author":"CK Mirabelli","year":"1988","unstructured":"Mirabelli, C. K. et al. A murine model to evaluate the ability of in vitro clonogenic assays to predict the response to tumors in vivo. Cancer Res 48, 5447\u20135454 (1988).","journal-title":"Cancer Res"},{"key":"28421_CR42","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3892\/ijmm.2012.1196","volume":"31","author":"D Kim","year":"2013","unstructured":"Kim, D., Suh, Y., Lee, H. & Lee, Y. Immune activation and antitumor response of ar-turmerone on P388D1 lymphoblast cell implanted tumors. Int J Mol Med 31, 386\u2013392, https:\/\/doi.org\/10.3892\/ijmm.2012.1196 (2013).","journal-title":"Int J Mol Med"},{"key":"28421_CR43","doi-asserted-by":"publisher","first-page":"8822","DOI":"10.1158\/0008-5472.CAN-05-4672","volume":"66","author":"RC Pong","year":"2006","unstructured":"Pong, R. C. et al. Mechanism of increased coxsackie and adenovirus receptor gene expression and adenovirus uptake by phytoestrogen and histone deacetylase inhibitor in human bladder cancer cells and the potential clinical application. Cancer Res 66, 8822\u20138828, https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-4672 (2006).","journal-title":"Cancer Res"},{"key":"28421_CR44","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/sj.cgt.7700726","volume":"11","author":"MD Sachs","year":"2004","unstructured":"Sachs, M. D. et al. Histone deacetylase inhibitors upregulate expression of the coxsackie adenovirus receptor (CAR) preferentially in bladder cancer cells. Cancer Gene Ther 11, 477\u2013486, https:\/\/doi.org\/10.1038\/sj.cgt.7700726 (2004).","journal-title":"Cancer Gene Ther"},{"key":"28421_CR45","doi-asserted-by":"publisher","first-page":"9592","DOI":"10.1093\/nar\/gkr698","volume":"39","author":"N Ai","year":"2011","unstructured":"Ai, N. et al. Signal-induced Brd4 release from chromatin is essential for its role transition from chromatin targeting to transcriptional regulation. Nucleic Acids Res 39, 9592\u20139604, https:\/\/doi.org\/10.1093\/nar\/gkr698 (2011).","journal-title":"Nucleic Acids Res"},{"key":"28421_CR46","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.molcel.2005.06.027","volume":"19","author":"MK Jang","year":"2005","unstructured":"Jang, M. K. et al. The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. Mol Cell 19, 523\u2013534, https:\/\/doi.org\/10.1016\/j.molcel.2005.06.027 (2005).","journal-title":"Mol Cell"},{"key":"28421_CR47","doi-asserted-by":"publisher","unstructured":"Budhiraja, S. & Rice, A. P. Reactivation of latent HIV: do all roads go through P-TEFb? Future Virol 8, https:\/\/doi.org\/10.2217\/fvl.13.52 (2013).","DOI":"10.2217\/fvl.13.52"},{"key":"28421_CR48","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1172\/JCI73805","volume":"124","author":"M Yamamoto","year":"2014","unstructured":"Yamamoto, M. et al. CDK9 inhibitor FIT-039 prevents replication of multiple DNA viruses. The Journal of clinical investigation 124, 3479\u20133488, https:\/\/doi.org\/10.1172\/JCI73805 (2014).","journal-title":"The Journal of clinical investigation"},{"key":"28421_CR49","first-page":"97","volume":"272","author":"D Brockmann","year":"2003","unstructured":"Brockmann, D. & Esche, H. The multifunctional role of E1A in the transcriptional regulation of CREB\/CBP-dependent target genes. Curr Top Microbiol Immunol 272, 97\u2013129 (2003).","journal-title":"Curr Top Microbiol Immunol"},{"key":"28421_CR50","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/978-1-4939-1804-1_30","volume":"1238","author":"BI Milavetz","year":"2015","unstructured":"Milavetz, B. I. & Balakrishnan, L. Viral epigenetics. Methods Mol Biol 1238, 569\u2013596, https:\/\/doi.org\/10.1007\/978-1-4939-1804-1_30 (2015).","journal-title":"Methods Mol Biol"},{"key":"28421_CR51","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.chom.2017.11.008","volume":"22","author":"NR Zemke","year":"2017","unstructured":"Zemke, N. R. & Berk, A. J. The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling. Cell Host Microbe 22, 789\u2013800 e785, https:\/\/doi.org\/10.1016\/j.chom.2017.11.008 (2017).","journal-title":"Cell Host Microbe"},{"key":"28421_CR52","doi-asserted-by":"publisher","first-page":"6701","DOI":"10.1128\/JVI.00380-12","volume":"86","author":"T Komatsu","year":"2012","unstructured":"Komatsu, T. & Nagata, K. Replication-uncoupled histone deposition during adenovirus DNA replication. J Virol 86, 6701\u20136711, https:\/\/doi.org\/10.1128\/JVI.00380-12 (2012).","journal-title":"J Virol"},{"key":"28421_CR53","doi-asserted-by":"publisher","first-page":"7577","DOI":"10.1093\/nar\/gku449","volume":"42","author":"F Itzen","year":"2014","unstructured":"Itzen, F., Greifenberg, A. K., Bosken, C. A. & Geyer, M. Brd4 activates P-TEFb for RNA polymerase II CTD phosphorylation. Nucleic Acids Res 42, 7577\u20137590, https:\/\/doi.org\/10.1093\/nar\/gku449 (2014).","journal-title":"Nucleic Acids Res"},{"key":"28421_CR54","doi-asserted-by":"publisher","first-page":"7527","DOI":"10.1093\/nar\/gkw585","volume":"44","author":"AJC Quaresma","year":"2016","unstructured":"Quaresma, A. J. C., Bugai, A. & Barboric, M. Cracking the control of RNA polymerase II elongation by 7SK snRNP and P-TEFb. Nucleic Acids Res 44, 7527\u20137539, https:\/\/doi.org\/10.1093\/nar\/gkw585 (2016).","journal-title":"Nucleic Acids Res"},{"issue":"Suppl 1","key":"28421_CR55","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1002\/bies.201670912","volume":"38","author":"J Zaborowska","year":"2016","unstructured":"Zaborowska, J., Isa, N. F. & Murphy, S. P-TEFb goes viral. Bioessays 38(Suppl 1), S75\u201385, https:\/\/doi.org\/10.1002\/bies.201670912 (2016).","journal-title":"Bioessays"},{"key":"28421_CR56","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S0092-8674(04)00402-7","volume":"117","author":"J You","year":"2004","unstructured":"You, J., Croyle, J. L., Nishimura, A., Ozato, K. & Howley, P. M. Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes. Cell 117, 349\u2013360 (2004).","journal-title":"Cell"},{"key":"28421_CR57","first-page":"6328","volume":"61","author":"M Kitazono","year":"2001","unstructured":"Kitazono, M., Goldsmith, M. E., Aikou, T., Bates, S. & Fojo, T. Enhanced adenovirus transgene expression in malignant cells treated with the histone deacetylase inhibitor FR901228. Cancer Res 61, 6328\u20136330 (2001).","journal-title":"Cancer Res"},{"key":"28421_CR58","doi-asserted-by":"publisher","first-page":"16030","DOI":"10.1038\/mtm.2016.30","volume":"3","author":"S Afkhami","year":"2016","unstructured":"Afkhami, S., Yao, Y. & Xing, Z. Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens. Mol Ther Methods Clin Dev 3, 16030, https:\/\/doi.org\/10.1038\/mtm.2016.30 (2016).","journal-title":"Mol Ther Methods Clin Dev"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28421-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28421-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28421-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T07:53:30Z","timestamp":1671609210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28421-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,1]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["28421"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-28421-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,1]]},"assertion":[{"value":"27 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"11554"}}